If you’ve been told that amyloid plaques are behind your memory loss or cognitive decline, there’s good news: new, science-backed treatments are helping patients fight back.
At Alzheimer’s Treatment Centers of America (ATCA), our precision-based therapies are designed to clear harmful buildup, reduce inflammation, and restore brain health — giving patients and families renewed hope for the future.
Amyloid plaques are abnormal protein deposits that disrupt communication between brain cells — a hallmark of Alzheimer’s disease.
Over time, they contribute to memory loss, confusion, and cognitive decline.
But now, breakthrough therapies can help reduce their impact and support brain recovery.
We combine AI-powered precision medicine with over 50 innovative treatment modalities to support brain detoxification and healing.
Our most effective approaches include:

A non-surgical, hospital-grade treatment that helps filter toxins and amyloid proteins from your blood, promoting cleaner circulation and a healthier brain environment. TPE may help improve memory, mental clarity and overall brain function.x

A cutting-edge antibody therapy that targets Galectin-3, a key driver of inflammation and plaque formation in the brain. Offered exclusively through FDA-approved clinical trials at ATCA, TB006 may slow progression and restore cognitive function.

We use advanced brainwave and cognitive testing to measure amyloid-related damage and track improvement over time — ensuring every treatment is customized to your biology.
In an observational study of our AI-protocol, 80% of patients had no further decline in their mild cognitive impairment.
Amyloid plaque buildup progresses silently. The earlier it’s addressed, the more brain function can be preserved.
Every month you wait could mean more irreversible damage.
Now is the time to act — and reclaim hope.
Call Now or Schedule Online — Appointments Fill Fast